#reports #UNH
United health (Biotechnology) reported for 2025 q1
(2025-04-17, Before Market Open):
- Revenue +9.8% YoY (vs +6.8% in previous quarter and historical rate +11.3%)
- EBITDA +14% YoY (vs +1.7% in previous quarter and historical rate +11.7%)
- EBITDA margin 9.3% increased compared to 8.9% same period last year
- Net Debt decreased by $0.8 bln since the start of the year (0.2% of market cap)
- FCF (LTM) -$6.6 bln (negative), 1.5% of market cap
- EV/EBITDA multiple is 12.8x compared to historical level (75th percentile) of 16.9x
expected multiple is 13.4x
At the opening of the session the share price went down -17.6% vs S&P500 +0.6%
According to our model the company`s growth potential is 36.5%
------------------------------------------------
#reports #NFLX
Netflix (The largest streaming service) reported for 2025 q1
(2025-04-17, After Market Close):
- Revenue +12.5% YoY (vs +16.0% in previous quarter and historical rate +9.8%)
- EBITDA +26% YoY (vs +48.6% in previous quarter and historical rate +29.8%)
- EBITDA margin 32.5% increased compared to 29.0% same period last year
- Net Debt increased by $0.6 bln since the start of the year (0.2% of market cap)
- FCF (LTM) +$7.2 bln (positive), 1.7% of market cap
- EV/EBITDA multiple is 37.1x compared to historical level (75th percentile) of 36.3x
expected multiple is 34.3x
------------------------------------------------
#reports #NKE
Nike (Sportswear and footwear manufacturer) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182883)
(2025-03-20, After Market Close):
- Revenue -9.3% YoY (vs -7.7% in previous quarter and historical rate 0.0%)
- EBITDA -41% YoY (vs -24.2% in previous quarter and historical rate -10.1%)
- EBITDA margin 7.0% decreased compared to 10.7% same period last year
- Net Debt decreased by $0.8 bln since the start of the year (0.9% of market cap)
- FCF (LTM) -$0.8 bln (negative), 0.9% of market cap
- EV/EBITDA multiple is 17.9x compared to historical level (75th percentile) of 30.6x
expected multiple is 17.3x
At the opening of the session the share price went down -7.3% vs S&P500 -0.6%
------------------------------------------------
#reports #ADBE
Adobe ( Software products and technologies developer) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182609)
(2025-03-12, After Market Close):
- Revenue +10.3% YoY (vs +11.1% in previous quarter and historical rate +11.0%)
- EBITDA +112.7% YoY (vs +10.7% in previous quarter and historical rate +13.4%)
- EBITDA margin 41.7% increased compared to 21.6% same period last year
- Net Debt increased by $1 bln since the start of the year (0.5% of market cap)
- FCF (LTM) +$1.4 bln (positive), 0.8% of market cap
- EV/EBITDA multiple is 20.3x compared to historical level (75th percentile) of 33.7x
expected multiple is 23.2x
At the opening of the session the share price went down -7.6% vs S&P500 -0.1%
Growth potential increased by 16.8% to +45.6%
------------------------------------------------
#reports #ORCL
Oracle (Software manufacturer, server hardware supplier) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182092)
(2025-03-10, After Market Close):
- Revenue +6.4% YoY (vs +8.6% in previous quarter and historical rate +9.7%)
- EBITDA +17.6% YoY (vs +16.0% in previous quarter and historical rate +23.0%)
- EBITDA margin 37.9% increased compared to 34.3% same period last year
- Net Debt increased by $1.2 bln since the start of the year (0.3% of market cap)
- EV/EBITDA multiple is 23.3x compared to historical level (75th percentile) of 25.2x
At the opening of the session the share price went down -3.6% vs S&P500 -0.2%
------------------------------------------------
#reports #TSLA
Tesla (Vehicles manufacturer) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=179554)
(2025-01-29, After Market Close):
- Revenue +2.1% YoY (vs +7.8% in previous quarter and historical rate +25.2%)
- EBITDA -9.9% YoY (vs +38.6% in previous quarter and historical rate +22.9%)
- EBITDA margin 12.0% decreased compared to 13.6% same period last year
- Net Debt decreased by $2.4 bln since the start of the year (0.3% of market cap)
- FCF (LTM) +$2.3 bln (positive), 0.3% of market cap
- EV/EBITDA multiple is 54.2x compared to historical level (75th percentile) of 63.4x
expected multiple is 44.6x
At the opening of the session the share price went up +5.6% vs S&P500 +0.2%
------------------------------------------------
#reports #MRK
Merck (Medical products and equipment manufacturer) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181127)
(2025-02-04, Before Market Open):
- Revenue +6.8% YoY (vs +4.4% in previous quarter and historical rate +9.1%)
- EBITDA +536600% YoY (vs -20.5% in previous quarter and historical rate +25.9%)
- EBITDA margin 34.4% increased compared to -7.4% same period last year
- Net Debt decreased by $0.1 bln since the start of the year (0.0% of market cap)
- FCF (LTM) -$0.6 bln (negative), 0.3% of market cap
- EV/EBITDA multiple is 10.8x compared to historical level (75th percentile) of 136x
expected multiple is -0.6x
At the opening of the session the share price went down -10.8% vs S&P500 0.0%
------------------------------------------------
#reports #DIS
Disney (Entertainment media conglomerate) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=179812)
(2025-02-05, Before Market Open):
- Revenue +4.8% YoY (vs +6.3% in previous quarter and historical rate +8.7%)
- EBITDA +22.3% YoY (vs +120.0% in previous quarter and historical rate +45.6%)
- EBITDA margin 26.9% increased compared to 23.0% same period last year
- Net Debt decreased by $0 bln since the start of the year (0.0% of market cap)
- FCF (LTM) +$1.4 bln (positive), 0.8% of market cap
- EV/EBITDA multiple is 10.3x compared to historical level (75th percentile) of 29.3x
expected multiple is 28.8x
At the opening of the session the share price went up +2.1% vs S&P500 -0.2%
------------------------------------------------
#reports #LLY
Eli Lilly (Medicines manufacturer) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=180596)
(2025-02-06, Before Market Open):
- Revenue +44.7% YoY (vs +20.4% in previous quarter and historical rate +17.8%)
- EBITDA -17.7% YoY (vs +131.5% in previous quarter and historical rate +38.7%)
- EBITDA margin 41.6% decreased compared to 73.2% same period last year
- Net Debt increased by $6 bln since the start of the year (0.8% of market cap)
- FCF (LTM) -$5.3 bln (negative), 0.7% of market cap
- EV/EBITDA multiple is 55.9x compared to historical level (75th percentile) of 60.2x
expected multiple is 24.7x
At the opening of the session the share price went down -0.3% vs S&P500 +0.3%
------------------------------------------------
#reports #WMT
Walmart (Chain of discount stores and supercenters) reported for 2024 q4
(2025-02-20, Before Market Open):
- Revenue +4.1% YoY (vs +5.5% in previous quarter and historical rate +6.0%)
- EBITDA +8.3% YoY (vs +8.5% in previous quarter and historical rate +7.5%)
- EBITDA margin 6.2% increased compared to 6.0% same period last year
- Net Debt decreased by $0.3 bln since the start of the year (0.0% of market cap)
- FCF (LTM) +$0.1 bln (positive), 0.0% of market cap
- EV/EBITDA multiple is 18.9x compared to historical level (75th percentile) of 15.3x
expected multiple is 18.6x
At the opening of the session the share price went down -5.0% vs S&P500 -0.1%
------------------------------------------------
#reports #AVGO
Broadcom (Digital and analog semiconductors developer ) reported for 2024 q4
(2024-12-12, After Market Close):
- Revenue +24.7% YoY (vs +51.2% in previous quarter and historical rate +25.1%)
- EBITDA +188.1% YoY (vs -7.7% in previous quarter and historical rate +16.0%)
- EBITDA margin 42.9% increased compared to 18.6% same period last year
- Net Debt decreased by $0.9 bln since the start of the year (0.1% of market cap)
- FCF (LTM) +$20.3 bln (positive), 2.4% of market cap
- EV/EBITDA multiple is 48.2x compared to historical level (75th percentile) of 47.1x
expected multiple is 64.3x
At the opening of the session the share price went up +18.4% vs S&P500 +0.2%
Growth potential changed insignificantly and equals -57.8%
------------------------------------------------
#reports #CRM
Salesforce ( Enterprise software developer) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181846)
(2025-02-26, After Market Close):
- Revenue +7.6% YoY (vs +8.3% in previous quarter and historical rate +12.9%)
- EBITDA -6.7% YoY (vs -2.8% in previous quarter and historical rate +41.0%)
- EBITDA margin 32.3% decreased compared to 37.2% same period last year
- Net Debt decreased by $1.3 bln since the start of the year (0.4% of market cap)
- FCF (LTM) -$0.3 bln (negative), 0.1% of market cap
- EV/EBITDA multiple is 22.5x compared to historical level (75th percentile) of 29.7x
expected multiple is 22.5x
At the opening of the session the share price went down -3.6% vs S&P500 +0.3%
------------------------------------------------
#reports #NVDA
Nvidia (Developer of graphics processors) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=180899)
(2025-02-26, After Market Close):
- Revenue +77.9% YoY (vs +93.6% in previous quarter and historical rate +82.9%)
- EBITDA +75.5% YoY (vs +107.1% in previous quarter and historical rate +81.4%)
- EBITDA margin 62.5% decreased compared to 63.3% same period last year
- Net Debt decreased by $2.9 bln since the start of the year (0.1% of market cap)
- FCF (LTM) +$25.4 bln (positive), 0.8% of market cap
- EV/EBITDA multiple is 37.7x compared to historical level (75th percentile) of 80.6x
- EV/EBITDA expected multiple is 32.8x
At the opening of the session the share price went down -1.9% vs S&P500 +0.3%
------------------------------------------------
#reports #LOW
Lowes Cos (Building materials seller) reported for 2024 q4
(2025-02-26, Before Market Open):
- Revenue -0.3% YoY (vs -1.5% in previous quarter and historical rate -4.3%)
- EBITDA +12.7% YoY (vs -6.7% in previous quarter and historical rate +1.5%)
- EBITDA margin 13.3% increased compared to 11.7% same period last year
- Net Debt increased by $37.5 bln since the start of the year (23.8% of market cap)
- FCF (LTM) +$3.7 bln (positive), 2.4% of market cap
- EV/EBITDA multiple is 15.8x compared to historical level (75th percentile) of 13.6x
At the opening of the session the share price went up +3.9% vs S&P500 +0.2%
------------------------------------------------
#reports #HD
Home Depot (Building materials and home improvement products retailer) reported for 2024 q4
(2025-02-25, Before Market Open):
- Revenue +14.1% YoY (vs +6.6% in previous quarter and historical rate +1.9%)
- EBITDA +6.7% YoY (vs -0.3% in previous quarter and historical rate -1.4%)
- EBITDA margin 13.4% decreased compared to 14.3% same period last year
- Net Debt decreased by $1.2 bln since the start of the year (0.3% of market cap)
- FCF (LTM) -$12.7 bln (negative), 3.2% of market cap
- EV/EBITDA multiple is 18.8x compared to historical level (75th percentile) of 16.8x
- EV/EBITDA expected multiple is 19.4x
At the opening of the session the share price went up +0.7% vs S&P500 -0.4%
Growth potential increased by 4.5% to -11.5%
------------------------------------------------
#reports #TMO
Thermo Fisher Scientific (Medical equipment manufacturer) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=180529)
(2025-01-30, Before Market Open):
- Revenue +4.7% YoY (vs +0.2% in previous quarter and historical rate +3.4%)
- EBITDA +8.2% YoY (vs +26.1% in previous quarter and historical rate -3.7%)
- EBITDA margin 20.2% increased compared to 19.6% same period last year
- Net Debt increased by $1.1 bln over the past reporting period (0.5% of market cap)
- FCF (LTM) -$1.4 bln (negative), 0.7% of market cap
- EV/EBITDA multiple is 22.1x compared to historical level (75th percentile) of 25.5x
- EV/EBITDA expected multiple is 20.3x
At the opening of the session the share price went up +3.9% vs S&P500 +0.2%
Growth potential decreased by 8.3% to +16.1%
------------------------------------------------
#reports #MDT
Medtronic (Medical device manufacturer) reported for 2024 q4
(2025-02-18, Before Market Open):
- Revenue +2.5% YoY (vs +5.2% in previous quarter and historical rate +1.5%)
- EBITDA +9.3% YoY (vs +12.8% in previous quarter and historical rate +4.8%)
- EBITDA margin 28.1% increased compared to 26.4% same period last year
- Net Debt decreased by $1.6 bln over the past reporting period (1.4% of market cap)
- FCF (LTM) -$3 bln (negative), 2.6% of market cap
- EV/EBITDA multiple is 16.6x compared to historical level (75th percentile) of 16.1x
At the opening of the session the share price went down -5.2% vs S&P500 +0.1%
------------------------------------------------
#reports #VZ
Verizon (Telecommunications company) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=180043)
(2025-01-24, Before Market Open):
- Revenue +1.6% YoY (vs 0.0% in previous quarter and historical rate +0.3%)
- EBITDA +133.1% YoY (vs -12.8% in previous quarter and historical rate +3.3%)
- EBITDA margin 33.4% increased compared to 14.6% same period last year
- Net Debt decreased by $0.9 bln over the past reporting period (0.5% of market cap)
- FCF (LTM) +$5.8 bln (positive), 3.4% of market cap
- EV/EBITDA multiple is 7.2x compared to historical level (75th percentile) of 8.4x
- EV/EBITDA expected multiple is 8.9x
At the opening of the session the share price went up +2.4% vs S&P500 +0.3%
Growth potential increased by 10.3% to +68.4%
------------------------------------------------
#reports #KO
Coca-Cola (Soft drinks poducer) reported for 2024 q4
(2025-02-11, Before Market Open):
- Revenue +6.4% YoY (vs -0.8% in previous quarter and historical rate +6.9%)
- EBITDA +17.3% YoY (vs -22.0% in previous quarter and historical rate +0.1%)
- EBITDA margin 25.9% increased compared to 23.4% same period last year
- Net Debt increased by $1.7 bln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0.2 bln (positive), 0.1% of market cap
- EV/EBITDA multiple is 30.1x compared to historical level (75th percentile) of 26.7x
- EV/EBITDA expected multiple is 33.8x
At the opening of the session the share price went up +4.6% vs S&P500 -0.2%
Growth potential decreased by 17.1% to -10.7%
------------------------------------------------
#reports #GILD
Gilead Sciences (Medicines manufacturer) reported for 2024 q4
(2025-02-11, After Market Close):
- Revenue +6.4% YoY (vs +7.0% in previous quarter and historical rate +3.0%)
- EBITDA +39.1% YoY (vs -654.7% in previous quarter and historical rate -40.1%)
- EBITDA margin 39.5% increased compared to 30.2% same period last year
- Net Debt decreased by $5 bln over the past reporting period (3.8% of market cap)
- FCF (LTM) +$1.6 bln (positive), 1.2% of market cap
- EV/EBITDA multiple is 188.8x compared to historical level (75th percentile) of 20.1x
At the opening of the session the share price went up +5.8% vs S&P500 -0.7%
------------------------------------------------
#reports #DD
DuPont (Chemical materials producer ) reported for 2024 q4
(2025-02-11, Before Market Open):
- Revenue +6.7% YoY (vs +4.4% in previous quarter and historical rate -8.7%)
- EBITDA +34100% YoY (vs +27.1% in previous quarter and historical rate -3.2%)
- EBITDA margin 11.1% increased compared to -11.1% same period last year
- Net Debt decreased by $0 bln over the past reporting period (0.1% of market cap)
- FCF (LTM) -$0.4 bln (negative), 1.0% of market cap
- EV/EBITDA multiple is 19.1x compared to historical level (75th percentile) of 24.9x
At the opening of the session the share price went up +4.6% vs S&P500 -0.2%
------------------------------------------------
#reports #CVS
CVS health (Prescription drug provider) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=179985)
(2025-02-12, Before Market Open):
- Revenue +4.2% YoY (vs +6.3% in previous quarter and historical rate +20.2%)
- EBITDA -20.7% YoY (vs -96.9% in previous quarter and historical rate -27.4%)
- EBITDA margin 1.7% decreased compared to 2.2% same period last year
- EV/EBITDA multiple is 18.6x compared to historical level (75th percentile) of 11.6x
At the opening of the session the share price went up +10.2% vs S&P500 -0.7%
------------------------------------------------
#reports #CSCO
Cisco (Internet protocol (IP)-based networking manufacturer) reported for 2024 q4
(2025-02-12, After Market Close):
- Revenue +9.4% YoY (vs -5.6% in previous quarter and historical rate +2.0%)
- EBITDA +10.1% YoY (vs -32.7% in previous quarter and historical rate -4.5%)
- EBITDA margin 27.7% increased compared to 27.5% same period last year
- Net Debt increased by $0.9 bln over the past reporting period (0.3% of market cap)
- FCF (LTM) -$25.2 bln (negative), 9.7% of market cap
- EV/EBITDA multiple is 20.2x compared to historical level (75th percentile) of 13.1x
- EV/EBITDA expected multiple is 25x
At the opening of the session the share price went up +2.2% vs S&P500 +0.2%
Growth potential decreased by 74.0% to -38.1%
------------------------------------------------
#reports #BMY
Bristol-Myers Squibb ( Pharmaceutical and nutritional products manufacturer ) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=180017)
(2025-02-06, Before Market Open):
- Revenue +7.5% YoY (vs +8.4% in previous quarter and historical rate +1.5%)
- EBITDA -89.5% YoY (vs -21.6% in previous quarter and historical rate -43.7%)
- EBITDA margin 1.4% decreased compared to 14.6% same period last year
- Net Debt decreased by $2.6 bln over the past reporting period (2.2% of market cap)
- FCF (LTM) -$13.6 bln (negative), 11.4% of market cap
- EV/EBITDA multiple is -18.8x compared to historical level (75th percentile) of 18.2x
- EV/EBITDA expected multiple is -22.6x
At the opening of the session the share price went down -3.9% vs S&P500 +0.3%
------------------------------------------------
#reports #MCD
McDonalds (Fast food chain) reported for 2024 q4
(2025-02-10, Before Market Open):
- Revenue -0.3% YoY (vs +2.7% in previous quarter and historical rate +4.0%)
- EBITDA -281.1% YoY (vs -9.2% in previous quarter and historical rate -12.2%)
- EBITDA margin -93.6% decreased compared to 51.5% same period last year
- Net Debt decreased by $50.2 bln over the past reporting period (22.0% of market cap)
- FCF (LTM) -$3.7 bln (negative), 1.6% of market cap
- EV/EBITDA multiple is 73x compared to historical level (75th percentile) of 21.3x
expected multiple is 22.3x
At the opening of the session the share price went up +1.1% vs S&P500 +0.3%
------------------------------------------------
#reports #QCOM
QUALCOMM (Producer of semiconductor and telecommunications equipment ) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=179827)
(2025-02-05, After Market Close):
- Revenue +17.5% YoY (vs +18.7% in previous quarter and historical rate +6.4%)
- EBITDA +18.6% YoY (vs +61.4% in previous quarter and historical rate +10.0%)
- EBITDA margin 34.2% increased compared to 33.9% same period last year
- Net Debt decreased by $1.1 bln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$4.9 bln (positive), 2.6% of market cap
- EV/EBITDA multiple is 15.4x compared to historical level (75th percentile) of 17.5x
expected multiple is 13x
At the opening of the session the share price went down -4.6% vs S&P500 +0.3%
Growth potential decreased by 25.7% to +15.4%
------------------------------------------------
#reports #PM
Philip Morris (Producer of cigarettes and tobacco products) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=179700)
(2025-02-06, Before Market Open):
- Revenue +7.3% YoY (vs +8.4% in previous quarter and historical rate +6.5%)
- EBITDA +15.3% YoY (vs +9.3% in previous quarter and historical rate +3.3%)
- EBITDA margin 38.5% increased compared to 35.8% same period last year
- Net Debt decreased by $3.6 bln over the past reporting period (1.6% of market cap)
- FCF (LTM) -$0.3 bln (negative), 0.1% of market cap
- EV/EBITDA multiple is 17.7x compared to historical level (75th percentile) of 15.6x
expected multiple is 18.2x
At the opening of the session the share price went up +11.4% vs S&P500 +0.3%
Growth potential decreased by 6.7% to -12.4%
------------------------------------------------
#reports #HON
Honeywell (Electronic control and automation systems manufacturer) reported for 2024 q4
(2025-02-06, Before Market Open):
- Revenue +6.9% YoY (vs +5.6% in previous quarter and historical rate +3.8%)
- EBITDA +212100% YoY (vs -0.9% in previous quarter and historical rate +3.6%)
- EBITDA margin 21.0% increased compared to -48.0% same period last year
- Net Debt increased by $0.2 bln over the past reporting period (0.2% of market cap)
- FCF (LTM) -$5.9 bln (negative), 4.1% of market cap
- EV/EBITDA multiple is 18.7x compared to historical level (75th percentile) of 75x
expected multiple is -17.8x
At the opening of the session the share price went down -3.3% vs S&P500 +0.3%
------------------------------------------------
#reports #AMZN
Amazon (E-commerce giant) reported for 2024 q4
(2025-02-06, After Market Close):
- Revenue -26.7% YoY (vs +11.0% in previous quarter and historical rate +7.6%)
- EBITDA -96.4% YoY (vs +32.3% in previous quarter and historical rate +20.3%)
- EBITDA margin 0.8% decreased compared to 15.9% same period last year
- Net Debt decreased by $19.1 bln over the past reporting period (0.8% of market cap)
- EV/EBITDA multiple is 28x compared to historical level (75th percentile) of 23.2x
expected multiple is 19.8x
At the opening of the session the share price went down -2.1% vs S&P500 +0.2%
------------------------------------------------
#reports #UPS
United Parcel Service (Logistic services provider) reported for [2024 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=177752)
(2024-10-24, Before Market Open):
- Revenue +90.8% YoY (vs +5.6% in previous quarter and historical rate +16.8%)
- EBITDA -70% YoY (vs -63.1% in previous quarter and historical rate +10.2%)
- EBITDA margin 10.3% decreased compared to 65.7% same period last year
- Net Debt decreased by $0.9 bln over the past reporting period (0.9% of market cap)
- EV/EBITDA multiple is 7.8x compared to historical level (75th percentile) of 9.5x
The company showed EPS +$1.8 per share. At the opening of the session the share price went up +10.6% vs S&P500 +0.4%
------------------------------------------------
#reports #UNH
United health (Biotechnology) reported for [2024 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=178637)
(2024-10-15, Before Market Open):
- Revenue +6.8% YoY (vs +9.2% in previous quarter and historical rate +11.7%)
- EBITDA +1.7% YoY (vs +2.3% in previous quarter and historical rate +10.8%)
- EBITDA margin 8.7% decreased compared to 9.2% same period last year
- Net Debt increased by $1.3 bln over the past reporting period (0.3% of market cap)
- FCF (LTM) -$14.7 bln (negative), 2.8% of market cap
- EV/EBITDA multiple is 15.2x compared to historical level (75th percentile) of 17.3x
expected multiple is 16.4x
The company showed EPS +$6.51 per share. At the opening of the session the share price went down -8.8% vs S&P500 +0.1%
------------------------------------------------
#reports #T
AT&T (Telecommunications company) reported for [2024 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=175838)
(2024-10-23, Before Market Open):
- Revenue +0.9% YoY (vs -0.5% in previous quarter and historical rate -9.3%)
- EBITDA +6.6% YoY (vs -31.3% in previous quarter and historical rate -2.2%)
- EBITDA margin 33.1% increased compared to 31.3% same period last year
- Net Debt decreased by $6.2 bln over the past reporting period (3.6% of market cap)
- FCF (LTM) +$10.8 bln (positive), 6.2% of market cap
- EV/EBITDA multiple is 8.3x compared to historical level (75th percentile) of 17.8x
expected multiple is 7.9x
The company showed EPS -$0.03 per share. At the opening of the session the share price went down -99.2% vs S&P500 -0.3%
Growth potential increased by 199.9% to +217.9%
------------------------------------------------
#reports #SLB
Schlumberger (Oilfield service company) reported for [2024 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=175424)
(2024-10-18, Before Market Open):
- Revenue +3.3% YoY (vs +16.2% in previous quarter and historical rate +15.6%)
- EBITDA -1.3% YoY (vs +19.8% in previous quarter and historical rate +63.8%)
- EBITDA margin 22.1% decreased compared to 23.1% same period last year
- Net Debt decreased by $2.3 bln over the past reporting period (3.9% of market cap)
- EV/EBITDA multiple is 7.7x compared to historical level (75th percentile) of 15x
The company showed EPS +$0.83 per share
------------------------------------------------
#reports #SBUX
Starbucks (Coffee selling company) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=SBUX&q=2024 q3&id=822530)
(2024-10-22, After Market Close):
- Revenue -0.3% YoY (vs -3.2% in previous quarter and historical rate +6.3%)
- EBITDA -17.4% YoY (vs -18.0% in previous quarter and historical rate -4.7%)
- EBITDA margin 16.3% decreased compared to 19.6% same period last year
- Net Debt decreased by $22.3 bln over the past reporting period (17.5% of market cap)
- EV/EBITDA multiple is 22.4x compared to historical level (75th percentile) of 20.2x
The company showed EPS +$0.8 per share
------------------------------------------------
#reports #RTX
Raytheon Technologies (Aircraft component supplier) reported for [2024 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=175329)
(2024-10-22, Before Market Open):
- Revenue +8.5% YoY (vs +49.2% in previous quarter and historical rate +8.8%)
- EBITDA +22% YoY (vs +303400.0% in previous quarter and historical rate +10.1%)
- EBITDA margin 16.0% increased compared to 14.2% same period last year
- Net Debt increased by $0.3 bln over the past reporting period (0.2% of market cap)
- FCF (LTM) +$1.2 bln (positive), 0.6% of market cap
- EV/EBITDA multiple is 20.9x compared to historical level (75th percentile) of 24.5x
expected multiple is 32.3x
The company showed EPS +$1.09 per share. At the opening of the session the share price went up +1.7% vs S&P500 -0.4%
Growth potential decreased by 19.0% to +24.0%
------------------------------------------------
#reports #PYPL
PayPal (Platform for digital and mobile payments) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=179637)
(2025-02-04, Before Market Open):
- Revenue +198.4% YoY (vs +5.8% in previous quarter and historical rate +24.0%)
- EBITDA +123.8% YoY (vs -1.0% in previous quarter and historical rate +16.8%)
- EBITDA margin 13.1% decreased compared to 17.5% same period last year
- EV/EBITDA multiple is 14.7x compared to historical level (75th percentile) of 29.2x
At the opening of the session the share price went down -8.1% vs S&P500 0.0%
------------------------------------------------
#reports #PG
Procter & Gamble (Consumer goods manufacturer) reported for [2024 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=175294)
(2024-10-18, Before Market Open):
- Revenue +2.1% YoY (vs -0.6% in previous quarter and historical rate +2.6%)
- EBITDA +28.5% YoY (vs +1.5% in previous quarter and historical rate +8.2%)
- EBITDA margin 29.5% increased compared to 23.4% same period last year
- Net Debt increased by $0.5 bln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$2.5 bln (positive), 0.6% of market cap
- EV/EBITDA multiple is 19.1x compared to historical level (75th percentile) of 19.9x
expected multiple is 31.1x
The company showed EPS +$1.58 per share. At the opening of the session the share price went down -1.1% vs S&P500 +0.3%
Growth potential decreased by 18.3% to +6.4%
------------------------------------------------
#reports #PFE
Pfizer (The largest farm company) reported for 2024 q4
(2025-02-04, Before Market Open):
- Revenue +24.7% YoY (vs +33.8% in previous quarter and historical rate -0.3%)
- EBITDA +150800% YoY (vs +757400.0% in previous quarter and historical rate +6.8%)
- EBITDA margin 8.5% increased compared to -18.3% same period last year
- Net Debt decreased by $58 bln over the past reporting period (39.9% of market cap)
- EV/EBITDA multiple is 13.9x compared to historical level (75th percentile) of 25.7x
expected multiple is 33.8x
At the opening of the session the share price went down -0.4% vs S&P500 0.0%
According to our model the company`s growth potential is 117.2%
------------------------------------------------
#reports #PEP
PepsiCo (Producer of soft drinks and other food products) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=179635)
(2025-02-04, Before Market Open):
- Revenue -0.2% YoY (vs -0.6% in previous quarter and historical rate +5.3%)
- EBITDA +23.9% YoY (vs -2.3% in previous quarter and historical rate +12.7%)
- EBITDA margin 11.8% increased compared to 9.5% same period last year
- Net Debt decreased by $0.2 bln over the past reporting period (0.1% of market cap)
- FCF (LTM) -$1.6 bln (negative), 0.8% of market cap
- EV/EBITDA multiple is 13.9x compared to historical level (75th percentile) of 19.1x
expected multiple is 13.7x
At the opening of the session the share price went down -2.8% vs S&P500 0.0%
Growth potential increased by 18.5% to +44.7%
------------------------------------------------
#reports #ORCL
Oracle (Software manufacturer, server hardware supplier) reported for [2024 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=175016)
(2024-09-09, After Market Close):
- Revenue +8.6% YoY (vs +6.9% in previous quarter and historical rate +9.5%)
- EBITDA +16% YoY (vs +19.6% in previous quarter and historical rate +20.8%)
- EBITDA margin 36.5% increased compared to 34.2% same period last year
- Net Debt increased by $3.7 bln over the past reporting period (0.8% of market cap)
- EV/EBITDA multiple is 27.8x compared to historical level (75th percentile) of 25x
The company showed EPS +$1.03 per share. At the opening of the session the share price went up +10.3% vs S&P500 +0.4%
------------------------------------------------
#reports #NKE
Nike (Sportswear and footwear manufacturer) reported for [2024 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=175204)
(2024-10-01, After Market Close):
- Revenue -7.7% YoY (vs -10.4% in previous quarter and historical rate +2.3%)
- EBITDA -24.2% YoY (vs -24.6% in previous quarter and historical rate -8.5%)
- EBITDA margin 11.2% decreased compared to 13.6% same period last year
- Net Debt increased by $0.5 bln over the past reporting period (0.4% of market cap)
- FCF (LTM) +$3.2 bln (positive), 2.6% of market cap
- EV/EBITDA multiple is 21.8x compared to historical level (75th percentile) of 30.6x
expected multiple is 4.3x
The company showed EPS +$0.7 per share. At the opening of the session the share price went down -7.0% vs S&P500 -0.2%
------------------------------------------------
#reports #MMM
3M Company (Wide range of interests: industry, healthcare and FMCG) reported for [2024 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=175316)
(2024-10-22, Before Market Open):
- Revenue -25% YoY (vs -24.3% in previous quarter and historical rate -8.1%)
- EBITDA +10.6% YoY (vs +223300.0% in previous quarter and historical rate -2.2%)
- EBITDA margin 32.2% increased compared to 21.8% same period last year
- Net Debt decreased by $0.6 bln over the past reporting period (0.7% of market cap)
- FCF (LTM) +$4.8 bln (positive), 5.6% of market cap
- EV/EBITDA multiple is 11.1x compared to historical level (75th percentile) of 10.8x
The company showed EPS +$2.48 per share. At the opening of the session the share price went up +4.0% vs S&P500 -0.4%
------------------------------------------------
#reports #JNJ
Johnson & Johnson (Medical goods and equipment manufacturer) reported for [2024 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=175434)
(2024-10-15, Before Market Open):
- Revenue +5.3% YoY (vs +5.2% in previous quarter and historical rate -1.3%)
- EBITDA -41.5% YoY (vs +49.3% in previous quarter and historical rate +14.2%)
- EBITDA margin 17.3% decreased compared to 31.0% same period last year
- EV/EBITDA multiple is 12x compared to historical level (75th percentile) of 18.1x
expected multiple is 10.8x
The company showed EPS +$1.11 per share. At the opening of the session the share price went down -1.0% vs S&P500 +0.1%
------------------------------------------------
#reports #INTC
Intel (Computer components manufacturer) reported for [2024 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=177995)
(2024-10-31, After Market Close):
- Revenue -7.4% YoY (vs -6.2% in previous quarter and historical rate -11.3%)
- EBITDA -49.8% YoY (vs -388.7% in previous quarter and historical rate -29.1%)
- EBITDA margin 19.0% decreased compared to 35.1% same period last year
- Net Debt increased by $2.2 bln over the past reporting period (2.8% of market cap)
- FCF (LTM) -$6.8 bln (negative), 8.6% of market cap
- EV/EBITDA multiple is -64.9x compared to historical level (75th percentile) of 25.6x
The company showed EPS -$3.88 per share. At the opening of the session the share price went up +6.9% vs S&P500 +0.3%
------------------------------------------------
#reports #IBM
IBM (Computer solutions and consulting service provider) reported for [2024 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=176091)
(2024-10-23, After Market Close):
- Revenue +1% YoY (vs +1.5% in previous quarter and historical rate -3.5%)
- EBITDA -10% YoY (vs -84.3% in previous quarter and historical rate -9.1%)
- EBITDA margin 25.2% decreased compared to 28.3% same period last year
- Net Debt decreased by $2.6 bln over the past reporting period (1.1% of market cap)
- FCF (LTM) +$2.7 bln (positive), 1.1% of market cap
- EV/EBITDA multiple is 26.7x compared to historical level (75th percentile) of 26x
The company showed EPS -$0.35 per share. At the opening of the session the share price went down -4.9% vs S&P500 +0.4%
------------------------------------------------
#reports #GOOG
Google (Web search and mobile software provider) reported for 2024 q4
(2025-02-04, After Market Close):
- Revenue -37.6% YoY (vs +15.1% in previous quarter and historical rate +6.9%)
- EBITDA -86.2% YoY (vs +30.0% in previous quarter and historical rate +3.3%)
- EBITDA margin 6.9% decreased compared to 31.3% same period last year
- Net Debt decreased by $3.8 bln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$17.9 bln (positive), 0.7% of market cap
- EV/EBITDA multiple is 25.2x compared to historical level (75th percentile) of 19.1x
expected multiple is 20x
At the opening of the session the share price went down -7.9% vs S&P500 -0.2%
------------------------------------------------
#reports #DHR
Danaher ( Medical equipment manufacturer ) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=DHR&q=2024 q3&id=815459)
(2024-10-22, Before Market Open):
- Revenue +2.1% YoY (vs -15.6% in previous quarter and historical rate -6.0%)
- EBITDA +6.9% YoY (vs -29.1% in previous quarter and historical rate -12.3%)
- EBITDA margin 24.7% increased compared to 23.5% same period last year
- Net Debt increased by $13.9 bln over the past reporting period (8.9% of market cap)
- EV/EBITDA multiple is 28.7x compared to historical level (75th percentile) of 27.5x
expected multiple is 27.2x
The company showed EPS +$1.12 per share. At the opening of the session the share price went down -3.0% vs S&P500 -0.4%
According to our model the company`s growth potential is negative
------------------------------------------------
#reports #CAT
Caterpillar ( Construction equipment manufacturer ) reported for [2024 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=178215)
(2024-10-30, Before Market Open):
- Revenue -5% YoY (vs +13.0% in previous quarter and historical rate +15.2%)
- EBITDA -6.7% YoY (vs +14.0% in previous quarter and historical rate +36.3%)
- EBITDA margin 21.1% decreased compared to 21.5% same period last year
- EV/EBITDA multiple is 11.4x compared to historical level (75th percentile) of 16.5x
The company showed EPS +$5.06 per share. At the opening of the session the share price went down -4.4% vs S&P500 0.0%
------------------------------------------------
#reports #BA
Boeing Company (Aviation, space and military equipment manufacturer ) reported for [2024 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=175363)
(2024-10-23, Before Market Open):
- Revenue -30.8% YoY (vs +208.1% in previous quarter and historical rate +20.6%)
- EBITDA -938.2% YoY (vs +436300.0% in previous quarter and historical rate -7.1%)
- EBITDA margin -23.8% decreased compared to 2.0% same period last year
- Net Debt decreased by $19.6 bln over the past reporting period (18.9% of market cap)
- EV/EBITDA multiple is 285.2x compared to historical level (75th percentile) of 334.7x
The company showed EPS -$9.97 per share. At the opening of the session the share price went up +0.1% vs S&P500 -0.3%
------------------------------------------------
#reports #AMD
Advanced Micro Devices (Semiconductor manufacturer) reported for 2024 q4
(2025-02-04, After Market Close):
- Revenue +24.2% YoY (vs +17.6% in previous quarter and historical rate +18.8%)
- EBITDA +42.5% YoY (vs +41.4% in previous quarter and historical rate +44.0%)
- EBITDA margin 21.2% increased compared to 18.5% same period last year
- Net Debt decreased by $2.9 bln over the past reporting period (1.5% of market cap)
- FCF (LTM) +$0.9 bln (positive), 0.5% of market cap
- EV/EBITDA multiple is 34.7x compared to historical level (75th percentile) of 97.7x
At the opening of the session the share price went down -10.0% vs S&P500 -0.2%
------------------------------------------------
#reports #ABT
Abbott (Medical products and equipment manufacturer ) reported for [2024 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=176415)
(2024-10-16, Before Market Open):
- Revenue +7.2% YoY (vs +4.9% in previous quarter and historical rate -0.4%)
- EBITDA -9.5% YoY (vs +10.9% in previous quarter and historical rate -9.1%)
- EBITDA margin 17.4% decreased compared to 20.6% same period last year
- Net Debt increased by $0 bln over the past reporting period (0.0% of market cap)
- FCF (LTM) +$7.6 bln (positive), 3.4% of market cap
- EV/EBITDA multiple is 28.9x compared to historical level (75th percentile) of 26.2x
expected multiple is 28.7x
The company showed EPS +$0.94 per share. At the opening of the session the share price went up +1.7% vs S&P500 0.0%
------------------------------------------------
#reports #ABBV
AbbVie ( Medicines manufacturer) reported for [2024 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=178358)
(2024-10-30, Before Market Open):
- Revenue +5.6% YoY (vs +3.8% in previous quarter and historical rate +0.1%)
- EBITDA -138.5% YoY (vs +62.4% in previous quarter and historical rate -22.2%)
- EBITDA margin -8.6% decreased compared to 23.6% same period last year
- Net Debt decreased by $63.8 bln over the past reporting period (19.0% of market cap)
- FCF (LTM) -$17.2 bln (negative), 5.1% of market cap
- EV/EBITDA multiple is 40.8x compared to historical level (75th percentile) of 23.4x
expected multiple is 32.8x
The company showed EPS +$0.88 per share. At the opening of the session the share price went up +0.8% vs S&P500 0.0%
------------------------------------------------
#reports #WMT
Walmart (Chain of discount stores and supercenters) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=WMT&q=2024 q3&id=831025)
(2024-11-19, Before Market Open):
- Revenue +5.5% YoY (vs +4.8% in previous quarter and historical rate +5.7%)
- EBITDA +8.5% YoY (vs +9.1% in previous quarter and historical rate +7.1%)
- EBITDA margin 5.9% increased compared to 5.7% same period last year
- Net Debt decreased by $0.8 bln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$5.9 bln (positive), 0.7% of market cap
- EV/EBITDA multiple is 21.1x compared to historical level (75th percentile) of 15.1x
expected multiple is 20.5x
The company showed EPS +$0.57 per share. At the opening of the session the share price went up +2.6% vs S&P500 -0.4%
Growth potential decreased by 5.6% to -27.9%
------------------------------------------------
#reports #V
Visa (Payment system) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=179585)
(2025-01-30, After Market Close):
- Revenue +10.1% YoY (vs +11.7% in previous quarter and historical rate +13.2%)
- EBITDA +4.7% YoY (vs +13.6% in previous quarter and historical rate +5.4%)
- EBITDA margin 53.8% decreased compared to 56.6% same period last year
- EV/EBITDA multiple is 32.6x compared to historical level (75th percentile) of 28.1x
expected multiple is 31.5x
At the opening of the session the share price went up +1.0% vs S&P500 +0.3%
------------------------------------------------
#reports #UPS
United Parcel Service (Logistic services provider) reported for 2024 q4
(2025-01-30, Before Market Open):
- Revenue +90.8% YoY (vs +5.6% in previous quarter and historical rate +16.8%)
- EBITDA -70% YoY (vs -63.1% in previous quarter and historical rate +10.2%)
- EBITDA margin 10.3% decreased compared to 65.7% same period last year
- Net Debt decreased by $0.9 bln over the past reporting period (0.9% of market cap)
- EV/EBITDA multiple is 7.8x compared to historical level (75th percentile) of 9.5x
At the opening of the session the share price went down -12.3% vs S&P500 +0.2%
------------------------------------------------
#reports #UNH
United health (Biotechnology) reported for 2024 q4
(2025-01-16, Before Market Open):
- Revenue +6.8% YoY (vs +9.2% in previous quarter and historical rate +11.7%)
- EBITDA +1.7% YoY (vs +2.3% in previous quarter and historical rate +10.8%)
- EBITDA margin 8.7% decreased compared to 9.2% same period last year
- Net Debt increased by $1.3 bln over the past reporting period (0.3% of market cap)
- FCF (LTM) -$14.7 bln (negative), 2.8% of market cap
- EV/EBITDA multiple is 15.6x compared to historical level (75th percentile) of 17.3x
expected multiple is 16.4x
At the opening of the session the share price went down -2.4% vs S&P500 +0.2%
------------------------------------------------
#reports #TXN
Texas Instruments (Semiconductor manufacturer) reported for 2024 q4
(2025-01-23, After Market Close):
- Revenue -1.7% YoY (vs -8.4% in previous quarter and historical rate -4.5%)
- EBITDA -3.1% YoY (vs -11.6% in previous quarter and historical rate -9.0%)
- EBITDA margin 45.2% decreased compared to 45.9% same period last year
- Net Debt increased by $0.9 bln over the past reporting period (0.5% of market cap)
- FCF (LTM) -$2.8 bln (negative), 1.7% of market cap
- EV/EBITDA multiple is 24.3x compared to historical level (75th percentile) of 19.4x
expected multiple is 25.5x
At the opening of the session the share price went down -5.3% vs S&P500 +0.3%
------------------------------------------------
#reports #TSLA
Tesla (Vehicles manufacturer) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=TSLA&q=2024 q3&id=816743)
(2024-10-23, After Market Close):
- Revenue +7.8% YoY (vs +2.3% in previous quarter and historical rate +30.5%)
- EBITDA +38.6% YoY (vs -17.6% in previous quarter and historical rate +39.5%)
- EBITDA margin 16.1% increased compared to 12.6% same period last year
- Net Debt decreased by $3 bln over the past reporting period (0.2% of market cap)
- FCF (LTM) +$4.5 bln (positive), 0.4% of market cap
- EV/EBITDA multiple is 95x compared to historical level (75th percentile) of 63.5x
expected multiple is 116.9x
The company showed EPS +$0.62 per share. At the opening of the session the share price went up +14.7% vs S&P500 +0.4%
------------------------------------------------
#reports #TMO
Thermo Fisher Scientific (Medical equipment manufacturer) reported for [2024 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=178641)
(2024-10-23, Before Market Open):
- Revenue +0.2% YoY (vs -1.4% in previous quarter and historical rate +3.2%)
- EBITDA +26.1% YoY (vs +28.9% in previous quarter and historical rate -5.5%)
- EBITDA margin 25.4% increased compared to 20.2% same period last year
- Net Debt increased by $2.2 bln over the past reporting period (1.0% of market cap)
- FCF (LTM) +$0.5 bln (positive), 0.2% of market cap
- EV/EBITDA multiple is 24.1x compared to historical level (75th percentile) of 25.7x
expected multiple is 21.3x
The company showed EPS +$4.24 per share. At the opening of the session the share price went down -2.0% vs S&P500 -0.3%
Growth potential decreased by 6.3% to +15.2%
------------------------------------------------
#reports #T
AT&T (Telecommunications company) reported for 2024 q4
(2025-01-27, Before Market Open):
- Revenue +0.9% YoY (vs -0.5% in previous quarter and historical rate -9.3%)
- EBITDA +6.6% YoY (vs -31.3% in previous quarter and historical rate -2.2%)
- EBITDA margin 33.1% increased compared to 31.3% same period last year
- Net Debt decreased by $6.2 bln over the past reporting period (3.6% of market cap)
- FCF (LTM) +$10.8 bln (positive), 6.2% of market cap
- EV/EBITDA multiple is 8.3x compared to historical level (75th percentile) of 17.8x
expected multiple is 7.9x
At the opening of the session the share price went down -99.2% vs S&P500 -2.0%
Growth potential increased by 202.2% to +220.2%
------------------------------------------------
#reports #SLB
Schlumberger (Oilfield service company) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=179480)
(2025-01-17, Before Market Open):
- Revenue +3.3% YoY (vs +16.2% in previous quarter and historical rate +15.6%)
- EBITDA -1.3% YoY (vs +19.8% in previous quarter and historical rate +63.8%)
- EBITDA margin 22.1% decreased compared to 23.1% same period last year
- Net Debt decreased by $2.3 bln over the past reporting period (3.9% of market cap)
- EV/EBITDA multiple is 7.8x compared to historical level (75th percentile) of 15x
At the opening of the session the share price went up +2.6% vs S&P500 +0.8%
------------------------------------------------
#reports #SBUX
Starbucks (Coffee selling company) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=179502)
(2025-01-28, After Market Close):
- Revenue -0.3% YoY (vs -3.2% in previous quarter and historical rate +6.3%)
- EBITDA -17.4% YoY (vs -18.0% in previous quarter and historical rate -4.7%)
- EBITDA margin 16.3% decreased compared to 19.6% same period last year
- Net Debt decreased by $22.3 bln over the past reporting period (17.5% of market cap)
- EV/EBITDA multiple is 22.4x compared to historical level (75th percentile) of 20.2x
At the opening of the session the share price went up +3.9% vs S&P500 -0.2%
------------------------------------------------
#reports #RTX
Raytheon Technologies (Aircraft component supplier) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=179611)
(2025-01-28, Before Market Open):
- Revenue +8.5% YoY (vs +49.2% in previous quarter and historical rate +8.8%)
- EBITDA +22% YoY (vs +303400.0% in previous quarter and historical rate +10.1%)
- EBITDA margin 16.0% increased compared to 14.2% same period last year
- Net Debt increased by $0.3 bln over the past reporting period (0.2% of market cap)
- FCF (LTM) +$1.2 bln (positive), 0.6% of market cap
- EV/EBITDA multiple is 20.8x compared to historical level (75th percentile) of 24.5x
expected multiple is 32.3x
At the opening of the session the share price went up +4.7% vs S&P500 +0.5%
Growth potential decreased by 18.6% to +24.5%
------------------------------------------------
#reports #PYPL
PayPal (Platform for digital and mobile payments) reported for [2024 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=175766)
(2024-10-29, Before Market Open):
- Revenue +5.8% YoY (vs +8.2% in previous quarter and historical rate +8.6%)
- EBITDA -1% YoY (vs +9.6% in previous quarter and historical rate +7.2%)
- EBITDA margin 12.9% decreased compared to 13.8% same period last year
- EV/EBITDA multiple is 20.3x compared to historical level (75th percentile) of 29.2x
The company showed EPS +$0.99 per share. At the opening of the session the share price went down -6.6% vs S&P500 -0.1%
------------------------------------------------
#reports #PM
Philip Morris (Producer of cigarettes and tobacco products) reported for [2024 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=175510)
(2024-10-22, Before Market Open):
- Revenue +8.4% YoY (vs +5.6% in previous quarter and historical rate +6.7%)
- EBITDA +9.3% YoY (vs +9.6% in previous quarter and historical rate +2.2%)
- EBITDA margin 41.9% increased compared to 41.6% same period last year
- Net Debt increased by $0.8 bln over the past reporting period (0.4% of market cap)
- FCF (LTM) -$0.5 bln (negative), 0.3% of market cap
- EV/EBITDA multiple is 17x compared to historical level (75th percentile) of 14.5x
expected multiple is 16.5x
The company showed EPS +$1.97 per share. At the opening of the session the share price went up +3.7% vs S&P500 -0.4%
Growth potential decreased by 10.5% to -16.3%
------------------------------------------------
#reports #PG
Procter & Gamble (Consumer goods manufacturer) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=179477)
(2025-01-22, Before Market Open):
- Revenue +2.1% YoY (vs -0.6% in previous quarter and historical rate +2.6%)
- EBITDA +28.5% YoY (vs +1.5% in previous quarter and historical rate +8.2%)
- EBITDA margin 29.5% increased compared to 23.4% same period last year
- Net Debt increased by $0.5 bln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$2.5 bln (positive), 0.6% of market cap
- EV/EBITDA multiple is 19.2x compared to historical level (75th percentile) of 19.9x
expected multiple is 31.1x
At the opening of the session the share price went up +3.3% vs S&P500 +0.6%
Growth potential decreased by 18.9% to +5.8%
------------------------------------------------
#reports #PFE
Pfizer (The largest farm company) reported for [2024 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=178417)
(2024-10-29, Before Market Open):
- Revenue +33.8% YoY (vs +4.3% in previous quarter and historical rate +6.3%)
- EBITDA +757400% YoY (vs -68.9% in previous quarter and historical rate +6.8%)
- EBITDA margin 42.8% increased compared to -16.4% same period last year
- Net Debt increased by $58 bln over the past reporting period (39.9% of market cap)
- EV/EBITDA multiple is 19.1x compared to historical level (75th percentile) of 25.7x
expected multiple is 33.8x
The company showed EPS +$0.78 per share. At the opening of the session the share price went up +0.5% vs S&P500 -0.1%
According to our model the company`s growth potential is 45.0%
------------------------------------------------
#reports #PEP
PepsiCo (Producer of soft drinks and other food products) reported for 2024 q3
(2024-10-08, Before Market Open):
- Revenue -0.6% YoY (vs +0.8% in previous quarter and historical rate +6.3%)
- EBITDA -2.3% YoY (vs +10.4% in previous quarter and historical rate +10.1%)
- EBITDA margin 19.8% decreased compared to 20.1% same period last year
- Net Debt decreased by $1.4 bln over the past reporting period (0.7% of market cap)
- FCF (LTM) -$2.2 bln (negative), 1.1% of market cap
- EV/EBITDA multiple is 14.5x compared to historical level (75th percentile) of 19.1x
expected multiple is 13.7x
The company showed EPS +$2.13 per share. At the opening of the session the share price went up +0.3% vs S&P500 +0.4%
------------------------------------------------
#reports #ORCL
Oracle (Software manufacturer, server hardware supplier) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=179200)
(2024-12-09, After Market Close):
- Revenue +8.6% YoY (vs +6.9% in previous quarter and historical rate +9.5%)
- EBITDA +16% YoY (vs +19.6% in previous quarter and historical rate +20.8%)
- EBITDA margin 36.5% increased compared to 34.2% same period last year
- Net Debt increased by $3.7 bln over the past reporting period (0.8% of market cap)
- EV/EBITDA multiple is 27.5x compared to historical level (75th percentile) of 25x
At the opening of the session the share price went down -8.9% vs S&P500 0.0%
------------------------------------------------
#reports #NKE
Nike (Sportswear and footwear manufacturer) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=179396)
(2024-12-19, After Market Close):
- Revenue -7.7% YoY (vs -10.4% in previous quarter and historical rate +2.3%)
- EBITDA -24.2% YoY (vs -24.6% in previous quarter and historical rate -8.5%)
- EBITDA margin 11.2% decreased compared to 13.6% same period last year
- Net Debt increased by $0.5 bln over the past reporting period (0.4% of market cap)
- FCF (LTM) +$3.2 bln (positive), 2.6% of market cap
- EV/EBITDA multiple is 22.3x compared to historical level (75th percentile) of 30.6x
expected multiple is 4.3x
At the opening of the session the share price went down -1.5% vs S&P500 -0.6%
------------------------------------------------
#reports #NFLX
Netflix (The largest streaming service) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=179496)
(2025-01-21, After Market Close):
- Revenue +16% YoY (vs +15.0% in previous quarter and historical rate +9.6%)
- EBITDA +48.6% YoY (vs +49.0% in previous quarter and historical rate +27.8%)
- EBITDA margin 23.0% increased compared to 17.9% same period last year
- Net Debt decreased by $0.8 bln over the past reporting period (0.2% of market cap)
- FCF (LTM) +$6.7 bln (positive), 1.6% of market cap
- EV/EBITDA multiple is 40.2x compared to historical level (75th percentile) of 35.2x
expected multiple is 38.9x
At the opening of the session the share price went up +14.8% vs S&P500 +0.6%
Growth potential decreased by 11.7% to -21.9%
------------------------------------------------
#reports #MSFT
Microsoft (Software developer and game consoles) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=179512)
(2025-01-29, After Market Close):
- Revenue +12.3% YoY (vs +16.0% in previous quarter and historical rate +12.5%)
- EBITDA +25.4% YoY (vs +27.8% in previous quarter and historical rate +14.6%)
- EBITDA margin 55.3% increased compared to 49.5% same period last year
- Net Debt increased by $7.6 bln over the past reporting period (0.2% of market cap)
- FCF (LTM) +$21.4 bln (positive), 0.7% of market cap
- EV/EBITDA multiple is 22.1x compared to historical level (75th percentile) of 25.6x
expected multiple is 21.5x
At the opening of the session the share price went down -5.3% vs S&P500 +0.2%
Growth potential increased by 1.9% to +18.5%
------------------------------------------------
#reports #MMM
3M Company (Wide range of interests: industry, healthcare and FMCG) reported for 2024 q4
(2025-01-21, Before Market Open):
- Revenue -25% YoY (vs -24.3% in previous quarter and historical rate -8.1%)
- EBITDA +10.6% YoY (vs +223300.0% in previous quarter and historical rate -2.2%)
- EBITDA margin 32.2% increased compared to 21.8% same period last year
- Net Debt decreased by $0.6 bln over the past reporting period (0.7% of market cap)
- FCF (LTM) +$4.8 bln (positive), 5.6% of market cap
- EV/EBITDA multiple is 11.1x compared to historical level (75th percentile) of 10.8x
At the opening of the session the share price went up +3.2% vs S&P500 +0.3%
------------------------------------------------
#reports #META
Facebook ( Social networking website) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=179555)
(2025-01-29, After Market Close):
- Revenue +20.6% YoY (vs +18.9% in previous quarter and historical rate +12.3%)
- EBITDA +10.6% YoY (vs +28.7% in previous quarter and historical rate +28.1%)
- EBITDA margin 57.5% decreased compared to 62.7% same period last year
- Net Debt decreased by $6.9 bln over the past reporting period (0.4% of market cap)
- FCF (LTM) -$25.5 bln (negative), 1.3% of market cap
- EV/EBITDA multiple is 22.1x compared to historical level (75th percentile) of 20.3x
expected multiple is 20.8x
At the opening of the session the share price went up +3.0% vs S&P500 +0.2%
------------------------------------------------
#reports #MDT
Medtronic (Medical device manufacturer) reported for [2024 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=177583)
(2024-11-19, Before Market Open):
- Revenue +5.2% YoY (vs +2.8% in previous quarter and historical rate +1.3%)
- EBITDA +12.8% YoY (vs 0.0% in previous quarter and historical rate +5.6%)
- EBITDA margin 27.0% increased compared to 25.2% same period last year
- Net Debt increased by $0.3 bln over the past reporting period (0.3% of market cap)
- FCF (LTM) -$3 bln (negative), 2.5% of market cap
- EV/EBITDA multiple is 17.6x compared to historical level (75th percentile) of 16.1x
The company showed EPS +$0.99 per share. At the opening of the session the share price went down -1.8% vs S&P500 -0.4%
------------------------------------------------
#reports #MCD
McDonalds (Fast food chain) reported for [2024 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=178452)
(2024-10-29, Before Market Open):
- Revenue +2.7% YoY (vs -0.1% in previous quarter and historical rate +5.1%)
- EBITDA -9.2% YoY (vs -11.8% in previous quarter and historical rate +5.3%)
- EBITDA margin 49.0% decreased compared to 55.4% same period last year
- Net Debt increased by $0.9 bln over the past reporting period (0.4% of market cap)
- FCF (LTM) -$5.8 bln (negative), 2.7% of market cap
- EV/EBITDA multiple is 20.2x compared to historical level (75th percentile) of 21.3x
expected multiple is 18.3x
The company showed EPS +$3.13 per share. At the opening of the session the share price went up +0.3% vs S&P500 -0.1%
------------------------------------------------
#reports #MA
Mastercard (Financial transaction processing services provider) reported for 2024 q4
(2025-01-30, Before Market Open):
- Revenue +14.4% YoY (vs +12.8% in previous quarter and historical rate +14.4%)
- EBITDA +19.7% YoY (vs +2.0% in previous quarter and historical rate +7.2%)
- EBITDA margin 44.6% increased compared to 42.6% same period last year
- EV/EBITDA multiple is 42.2x compared to historical level (75th percentile) of 36.9x
expected multiple is 43.9x
At the opening of the session the share price went up +1.1% vs S&P500 +0.2%
Growth potential decreased by 73.1% to -27.7%
------------------------------------------------
#reports #LOW
Lowes Cos (Building materials seller) reported for [2024 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=177569)
(2024-11-19, Before Market Open):
- Revenue -1.5% YoY (vs -5.5% in previous quarter and historical rate -3.9%)
- EBITDA -6.7% YoY (vs -11.3% in previous quarter and historical rate +2.0%)
- EBITDA margin 14.7% decreased compared to 15.5% same period last year
- EV/EBITDA multiple is 16.5x compared to historical level (75th percentile) of 13.5x
The company showed EPS +$2.99 per share. At the opening of the session the share price went down -3.2%
------------------------------------------------
#reports #LLY
Eli Lilly (Medicines manufacturer) reported for [2024 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=175849)
(2024-10-30, Before Market Open):
- Revenue +20.4% YoY (vs +36.0% in previous quarter and historical rate +14.7%)
- EBITDA +145.9% YoY (vs +57.3% in previous quarter and historical rate +39.3%)
- EBITDA margin 18.5% increased compared to 9.1% same period last year
- Net Debt increased by $2.1 bln over the past reporting period (0.3% of market cap)
- FCF (LTM) -$9.9 bln (negative), 1.3% of market cap
- EV/EBITDA multiple is 50x compared to historical level (75th percentile) of 59.7x
expected multiple is 50.3x
The company showed EPS +$1.07 per share. At the opening of the session the share price went down -11.0% vs S&P500 0.0%
Growth potential increased by 53.9% to +14.4%
------------------------------------------------
#reports #KO
Coca-Cola (Soft drinks poducer) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=KO&q=2024 q3&id=816569)
(2024-10-23, Before Market Open):
- Revenue -0.8% YoY (vs +3.3% in previous quarter and historical rate +7.2%)
- EBITDA -22% YoY (vs +8.2% in previous quarter and historical rate -3.6%)
- EBITDA margin 23.4% decreased compared to 29.8% same period last year
- Net Debt increased by $3.4 bln over the past reporting period (1.2% of market cap)
- FCF (LTM) -$3.5 bln (negative), 1.3% of market cap
- EV/EBITDA multiple is 28.4x compared to historical level (75th percentile) of 26.1x
expected multiple is 24.9x
The company showed EPS +$0.66 per share. At the opening of the session the share price went down -3.5% vs S&P500 -0.3%
------------------------------------------------
#reports #JNJ
Johnson & Johnson (Medical goods and equipment manufacturer) reported for 2024 q4
(2025-01-22, Before Market Open):
- Revenue +5.3% YoY (vs +5.2% in previous quarter and historical rate -1.3%)
- EBITDA -41.5% YoY (vs +49.3% in previous quarter and historical rate +14.2%)
- EBITDA margin 17.3% decreased compared to 31.0% same period last year
- EV/EBITDA multiple is 12x compared to historical level (75th percentile) of 18.1x
expected multiple is 10.8x
At the opening of the session the share price went down -2.8% vs S&P500 +0.6%
------------------------------------------------
#reports #INTC
Intel (Computer components manufacturer) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=179594)
(2025-01-30, After Market Close):
- Revenue -7.4% YoY (vs -6.2% in previous quarter and historical rate -11.3%)
- EBITDA -49.8% YoY (vs -388.7% in previous quarter and historical rate -29.1%)
- EBITDA margin 19.0% decreased compared to 35.1% same period last year
- Net Debt increased by $2.2 bln over the past reporting period (2.8% of market cap)
- FCF (LTM) -$6.8 bln (negative), 8.6% of market cap
- EV/EBITDA multiple is -65.3x compared to historical level (75th percentile) of 25.6x
At the opening of the session the share price went up +0.4% vs S&P500 +0.3%
------------------------------------------------
#reports #IBM
IBM (Computer solutions and consulting service provider) reported for 2024 q4
(2025-01-29, After Market Close):
- Revenue +1% YoY (vs +1.5% in previous quarter and historical rate -3.5%)
- EBITDA -10% YoY (vs -84.3% in previous quarter and historical rate -9.1%)
- EBITDA margin 25.2% decreased compared to 28.3% same period last year
- Net Debt decreased by $2.6 bln over the past reporting period (1.1% of market cap)
- FCF (LTM) +$2.7 bln (positive), 1.1% of market cap
- EV/EBITDA multiple is 26.8x compared to historical level (75th percentile) of 26x
At the opening of the session the share price went up +9.3% vs S&P500 +0.2%
------------------------------------------------
#reports #HON
Honeywell (Electronic control and automation systems manufacturer) reported for [2024 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=175451)
(2024-10-24, Before Market Open):
- Revenue +5.6% YoY (vs +4.7% in previous quarter and historical rate +3.0%)
- EBITDA -0.9% YoY (vs +5.5% in previous quarter and historical rate -13.6%)
- EBITDA margin 22.8% decreased compared to 24.3% same period last year
- Net Debt increased by $1.8 bln over the past reporting period (1.2% of market cap)
- FCF (LTM) -$6.1 bln (negative), 4.0% of market cap
- EV/EBITDA multiple is 81.2x compared to historical level (75th percentile) of 75x
expected multiple is -17.8x
The company showed EPS +$2.16 per share. At the opening of the session the share price went down -2.4% vs S&P500 +0.4%
------------------------------------------------
#reports #HD
Home Depot (Building materials and home improvement products retailer) reported for [2024 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=177107)
(2024-11-12, Before Market Open):
- Revenue +6.6% YoY (vs +0.6% in previous quarter and historical rate +1.6%)
- EBITDA -0.3% YoY (vs -1.5% in previous quarter and historical rate -0.6%)
- EBITDA margin 15.4% decreased compared to 16.5% same period last year
- Net Debt decreased by $1.2 bln over the past reporting period (0.3% of market cap)
- FCF (LTM) -$14 bln (negative), 3.3% of market cap
- EV/EBITDA multiple is 19.9x compared to historical level (75th percentile) of 16.5x
expected multiple is 20.8x
The company showed EPS +$3.67 per share. At the opening of the session the share price went up +1.5% vs S&P500 +0.1%
According to our model the company`s growth potential is negative
------------------------------------------------
#reports #GILD
Gilead Sciences (Medicines manufacturer) reported for [2024 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=178054)
(2024-11-06, After Market Close):
- Revenue +7% YoY (vs +5.4% in previous quarter and historical rate +4.2%)
- EBITDA -654.7% YoY (vs +47.8% in previous quarter and historical rate -26.7%)
- EBITDA margin -19.5% decreased compared to 3.8% same period last year
- Net Debt decreased by $2.3 bln over the past reporting period (1.8% of market cap)
- FCF (LTM) -$3 bln (negative), 2.4% of market cap
- EV/EBITDA multiple is -604.5x compared to historical level (75th percentile) of 20x
The company showed EPS +$1 per share. At the opening of the session the share price went up +2.5% vs S&P500 +0.2%
------------------------------------------------
#reports #DHR
Danaher ( Medical equipment manufacturer ) reported for 2024 q4
(2025-01-29, Before Market Open):
- Revenue +2.1% YoY (vs -15.6% in previous quarter and historical rate -6.0%)
- EBITDA +6.9% YoY (vs -29.1% in previous quarter and historical rate -12.3%)
- EBITDA margin 24.7% increased compared to 23.5% same period last year
- Net Debt increased by $13.9 bln over the past reporting period (8.9% of market cap)
- EV/EBITDA multiple is 29x compared to historical level (75th percentile) of 27.5x
expected multiple is 27.2x
At the opening of the session the share price went down -4.4% vs S&P500 -0.2%
According to our model the company`s growth potential is negative
------------------------------------------------
#reports #CVS
CVS health (Prescription drug provider) reported for [2024 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=178547)
(2024-11-06, Before Market Open):
- Revenue +6.3% YoY (vs +2.6% in previous quarter and historical rate +20.8%)
- EBITDA -96.9% YoY (vs -7.6% in previous quarter and historical rate -26.1%)
- EBITDA margin 0.1% decreased compared to 2.5% same period last year
- EV/EBITDA multiple is 14.7x compared to historical level (75th percentile) of 11.6x
The company showed EPS +$0.07 per share. At the opening of the session the share price went up +11.5% vs S&P500 +1.6%
------------------------------------------------
#reports #CMCSA
Comcast (Telecommunications company) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=179581)
(2025-01-30, Before Market Open):
- Revenue +2.1% YoY (vs +6.5% in previous quarter and historical rate +2.2%)
- EBITDA +10.1% YoY (vs -2.3% in previous quarter and historical rate +14.4%)
- EBITDA margin 27.7% increased compared to 25.6% same period last year
- Net Debt decreased by $0.8 bln over the past reporting period (0.6% of market cap)
- FCF (LTM) -$0.8 bln (negative), 0.6% of market cap
- EV/EBITDA multiple is 5.8x compared to historical level (75th percentile) of 9x
expected multiple is 6.1x
At the opening of the session the share price went down -7.9% vs S&P500 +0.2%
------------------------------------------------
#reports #CAT
Caterpillar ( Construction equipment manufacturer ) reported for 2024 q4
(2025-01-30, Before Market Open):
- Revenue -5% YoY (vs +13.0% in previous quarter and historical rate +15.2%)
- EBITDA -6.7% YoY (vs +14.0% in previous quarter and historical rate +36.3%)
- EBITDA margin 21.1% decreased compared to 21.5% same period last year
- EV/EBITDA multiple is 11.5x compared to historical level (75th percentile) of 16.5x
At the opening of the session the share price went down -5.0% vs S&P500 +0.2%
------------------------------------------------
#reports #BMY
Bristol-Myers Squibb ( Pharmaceutical and nutritional products manufacturer ) reported for [2024 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=176228)
(2024-10-31, Before Market Open):
- Revenue +8.4% YoY (vs +8.7% in previous quarter and historical rate +1.6%)
- EBITDA -21.6% YoY (vs -30.8% in previous quarter and historical rate -19.6%)
- EBITDA margin 14.1% decreased compared to 19.5% same period last year
- Net Debt decreased by $4.2 bln over the past reporting period (3.4% of market cap)
- FCF (LTM) -$11.8 bln (negative), 9.4% of market cap
- EV/EBITDA multiple is -24.2x compared to historical level (75th percentile) of 18.3x
expected multiple is -23.1x
The company showed EPS +$0.6 per share. At the opening of the session the share price went up +2.2% vs S&P500 -0.7%
------------------------------------------------
#reports #BA
Boeing Company (Aviation, space and military equipment manufacturer ) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=179612)
(2025-01-28, Before Market Open):
- Revenue -30.8% YoY (vs +208.1% in previous quarter and historical rate +20.6%)
- EBITDA -938.2% YoY (vs +436300.0% in previous quarter and historical rate -7.1%)
- EBITDA margin -23.8% decreased compared to 2.0% same period last year
- Net Debt decreased by $19.6 bln over the past reporting period (18.9% of market cap)
- EV/EBITDA multiple is 281.8x compared to historical level (75th percentile) of 334.7x
At the opening of the session the share price went up +3.0% vs S&P500 +0.5%
------------------------------------------------
#reports #AMD
Advanced Micro Devices (Semiconductor manufacturer) reported for [2024 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=176079)
(2024-10-29, After Market Close):
- Revenue +17.6% YoY (vs +8.9% in previous quarter and historical rate +20.9%)
- EBITDA +41.4% YoY (vs +25.2% in previous quarter and historical rate +48.9%)
- EBITDA margin 21.7% increased compared to 18.1% same period last year
- Net Debt increased by $3.1 bln over the past reporting period (1.6% of market cap)
- FCF (LTM) +$1 bln (positive), 0.5% of market cap
- EV/EBITDA multiple is 42.7x compared to historical level (75th percentile) of 97.7x
The company showed EPS +$0.47 per share. At the opening of the session the share price went down -4.5% vs S&P500 0.0%
------------------------------------------------
#reports #ADBE
Adobe ( Software products and technologies developer) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=179454)
(2024-12-11, After Market Close):
- Revenue +11.1% YoY (vs +10.6% in previous quarter and historical rate +10.9%)
- EBITDA +10.7% YoY (vs +15.1% in previous quarter and historical rate +4.8%)
- EBITDA margin 38.8% decreased compared to 38.9% same period last year
- Net Debt decreased by $0.4 bln over the past reporting period (0.2% of market cap)
- FCF (LTM) +$0.1 bln (positive), 0.0% of market cap
- EV/EBITDA multiple is 26.1x compared to historical level (75th percentile) of 33.8x
expected multiple is 25.5x
The company showed EPS +$3.8 per share. At the opening of the session the share price went down -11.4% vs S&P500 -0.2%
Growth potential decreased by 10.6% to +15.4%
------------------------------------------------
#reports #ABT
Abbott (Medical products and equipment manufacturer ) reported for 2024 q4
(2025-01-22, Before Market Open):
- Revenue +7.2% YoY (vs +4.9% in previous quarter and historical rate -0.4%)
- EBITDA -9.5% YoY (vs +10.9% in previous quarter and historical rate -9.1%)
- EBITDA margin 17.4% decreased compared to 20.6% same period last year
- Net Debt increased by $0 bln over the past reporting period (0.0% of market cap)
- FCF (LTM) +$7.6 bln (positive), 3.4% of market cap
- EV/EBITDA multiple is 28.8x compared to historical level (75th percentile) of 26.2x
expected multiple is 28.7x
At the opening of the session the share price went down -2.3% vs S&P500 +0.6%
------------------------------------------------
#reports #ABBV
AbbVie ( Medicines manufacturer) reported for 2024 q4
(2025-01-31, Before Market Open):
- Revenue +5.6% YoY (vs +3.8% in previous quarter and historical rate +0.1%)
- EBITDA -138.5% YoY (vs +62.4% in previous quarter and historical rate -22.2%)
- EBITDA margin -8.6% decreased compared to 23.6% same period last year
- Net Debt decreased by $63.8 bln over the past reporting period (19.0% of market cap)
- FCF (LTM) -$17.2 bln (negative), 5.1% of market cap
- EV/EBITDA multiple is 40.5x compared to historical level (75th percentile) of 23.4x
expected multiple is 32.8x
At the opening of the session the share price went up +6.6% vs S&P500 +0.3%
------------------------------------------------
#reports #AAPL
Apple ( Personal and tablet computers, smartphones, software manufacturer) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=179592)
(2025-01-30, After Market Close):
- Revenue +4% YoY (vs +6.1% in previous quarter and historical rate +1.8%)
- EBITDA +6.7% YoY (vs +7.4% in previous quarter and historical rate +2.9%)
- EBITDA margin 36.9% increased compared to 36.0% same period last year
- Net Debt increased by $1.6 bln over the past reporting period (0.0% of market cap)
- FCF (LTM) +$19.4 bln (positive), 0.5% of market cap
- EV/EBITDA multiple is 27.1x compared to historical level (75th percentile) of 24.9x
expected multiple is 26.7x
At the opening of the session the share price went up +4.0%
Growth potential changed insignificantly and equals -7.7%
------------------------------------------------
#reports #VZ
Verizon (Telecommunications company) reported for [2024 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=175626)
(2024-10-22, Before Market Open):
- Revenue -0% YoY (vs +0.6% in previous quarter and historical rate 0.0%)
- EBITDA -12.8% YoY (vs +6.2% in previous quarter and historical rate -7.6%)
- EBITDA margin 31.2% decreased compared to 35.7% same period last year
- Net Debt decreased by $1.4 bln over the past reporting period (0.8% of market cap)
- FCF (LTM) -$1.3 bln (negative), 0.8% of market cap
- EV/EBITDA multiple is 8.4x compared to historical level (75th percentile) of 8.3x
expected multiple is 8.6x
The company showed EPS +$0.78 per share. At the opening of the session the share price went down -4.1% vs S&P500 -0.4%
------------------------------------------------
#reports #VZ
Verizon (Telecommunications company) reported for [2024 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=170735)
(2024-07-22, Before Market Open):
- Revenue +0.6% YoY (vs +0.2% in previous quarter and historical rate +0.4%)
- EBITDA +44.6% YoY (vs +0.5% in previous quarter and historical rate -1.8%)
- EBITDA margin 51.1% increased compared to 35.5% same period last year
- Net Debt decreased by $2.7 bln over the past reporting period (1.7% of market cap)
- FCF (LTM) +$7.7 bln (positive), 4.6% of market cap
- EV/EBITDA multiple is 7.4x compared to historical level (75th percentile) of 7.8x
expected multiple is 8.4x
The company showed EPS +$1.09 per share. At the opening of the session the share price went down -4.0% vs S&P500 +0.7%
Growth potential increased by 75.1% to +59.4%
------------------------------------------------
#reports #V
Visa (Payment system) reported for [2024 q3](https://eninvs.com/press_release.php?ticker=V&q=2024 q3&id=820288)
(2024-10-29, After Market Close):
- Revenue +112% YoY (vs +9.6% in previous quarter and historical rate +22.7%)
- EBITDA +118.1% YoY (vs +17.2% in previous quarter and historical rate +15.7%)
- EBITDA margin 55.9% increased compared to 54.4% same period last year
- EV/EBITDA multiple is 24.4x compared to historical level (75th percentile) of 27.5x
expected multiple is 19.8x
The company showed EPS +$2.34 per share. At the opening of the session the share price went up +2.7% vs S&P500 0.0%
Growth potential increased by 35.6% to +38.8%
Country: UNITED STATES
Sector: Drug Manufacturers — General
Quarterly values ($m)
Change (y/y)
FCF ($m)
Net Debt / Cash and Equivalents ($m)
EV / EBITDA
Potential dynamics
